Urologix Com (NASDAQ:ULGX)

CAPS Rating: No stars

The Company develops, manufactures and markets non-surgical, catheter-based therapies that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia.

No one has written a Pitch for ULGX yet. Tell us why you think ULGX will outperform or underperform the market.

Featured Broker Partners